Ethyl 2-(3-((tert-Butoxycarbonyl)amino)bicyclo[1.1.1]pentan-1-yl)acetate, 98%, 250mg

Salzsäure, 20 %, techn., 10 l, kunststoffverpackung.

4-Chloro-2-methyl-5-nitropyrimidine, 96%, 1g

2-amino-N-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)acetamide hydrochloride, 95.0%, 250mg

2-Chloro-3-phenylquinoxaline, 97%, 5g

5-Amino-2-pyridinol hydrochloride, 97.0%, 25g

2-Amino-1-(3-methoxy-phenyl)-ethanone; hydrochloride, 95.0%, 1g

4-Amino-6-methyl-2-(methylthio)pyrimidine-5-carbaldehyde, 95.0%, 100mg

3-Hydroxy-4-(trifluoromethyl)benzoic acid, 95%, 250mg

[3-(2-Dimethylamino-5-trifluoromethyl-pyridin-3-yl)-phenyl]-methanol, 95.0%, 5g

4-Phenoxybenzhydrazide, 97%, 5g

1-Oxa-spiro[4.5]decan-8-one, 95.0%, 250mg

4-Methylbenzyl acetate, 97.0%, 100g